cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2004; 44:1429-1435, doi:10.1016/j.jacc.2004.06.070
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hovingh, G. K.
Right arrow Articles by Kastelein, J. J.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hovingh, G. K.
Right arrow Articles by Kastelein, J. J.P.

A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease

G. Kees Hovingh, MD*, Alison Brownlie, PhD{dagger}, Radjesh J. Bisoendial, MD*, Marie Pierre Dube, PhD{dagger}, Johannes H.M. Levels, PhD*, Wilma Petersen, BSc*, Robin P.F. Dullaart, MD, PhD{ddagger}, Erik S.G. Stroes, MD, PhD*, Aeilko H. Zwinderman, PhD§, Eric de Groot, MD, PhD*, Michael R. Hayden, MD, PhD, ChB{dagger},||, Jan Albert Kuivenhoven, PhD* and John J.P. Kastelein, MD, PhD*,*

* Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
{dagger} Xenon Genetics Inc., Vancouver, British Columbia, Canada
{ddagger} Department of Internal Medicine, Academic Hospital, Groningen, The Netherlands
§ Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands
|| Center for Molecular Medicine and Therapeutics, Children and Women's Hospital, University of British Columbia, Vancouver, British Columbia, Canada



View larger version (16K):

[in a new window]
 
Figure 1 Log-transformed (logFMD) results are significantly lower in carriers of the apoA-I (L178P) mutation compared with family controls. Inverted triangles = apoA-I (L178P) carriers; circles = family controls.

 


View larger version (28K):

[in a new window]
 
Figure 2 Mean combined carotid intima media thickness (IMT) increase per year of age is significantly higher in heterozygotes compared with controls. The rate of progression of carotid wall thickening over time is similar in L178P heterozygotes and familial hypercholesterolemia (FH) patients. Solid circles = ApoA-I (L178P) carriers; open diamonds = patients with FH; + = family controls.

 


View larger version (11K):

[in a new window]
 
Figure 3 Event-free survival is significantly lower in apoA-I (L178P) carriers than in controls. Bottom broken line = apoA-I (L178P) carriers; top line = family controls. p = 0.008.

 




 
  cardiology careers collections past issues search home